Amlodipine Completed Phase 1 Trials for High Blood Pressure (Hypertension) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03657550Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects
NCT03662620Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers
NCT01337674Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)
NCT01648231Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers
NCT02075619Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions
NCT01130168The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)
NCT01536353Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301
NCT01797926Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions
NCT01822639A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study
NCT02064556CKD-330 Drug-Drug Interaction Study (Amlodipine)
NCT02064621CKD-330 Drug-Drug Interaction Study (Candesartan)
NCT02186496Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)
NCT02548286Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs
NCT02801526Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A
NCT02811731Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B